METROPOLIS HEALTHCARE LTD (METROPOLIS) financials

METROPOLIS HEALTHCARE LTD (METROPOLIS) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Metropolis Healthcare Limited is one of the leading Indian diagnostics companies. The Company owns a chain of diagnostic centres across India, South Asia, Africa and the Middle East.

Market Cap: ₹11,003Cr.
Current Price: ₹530
Stock P/E: 61.6
ROE: 12.2%
ROCE: 15.9%
Book Value: ₹67.0
Dividend Yield: 0.38%
52W High / Low: ₹609/412

In Jun 2026, METROPOLIS HEALTHCARE LTD (METROPOLIS) reported sales ₹372 Cr and net profit ₹51 Cr.

Annual TTM: sales ₹1,415 Cr, net profit ₹172 Cr.

Shareholding: Promoters 48.86% (Jun 2026), FIIs 11.03% (Jun 2026), DIIs 35.12% (Jun 2026), Public 5.00% (Jun 2026), No. of Shareholders 50,636% (Jun 2026).

METROPOLIS quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	322	297	312	324	356	335	352	372
Expenses	240	232	259	247	264	255	262	279
Operating Profit	82	65	53	77	91	80	90	94
OPM %	26%	22%	17%	24%	26%	24%	26%	25%
Other Income	4	3	8	3	3	-6	9	5
Interest	5	4	4	4	4	4	7	5
Depreciation	26	27	27	28	28	28	33	28
Profit before tax	55	37	29	48	62	42	60	66
Tax %	23%	26%	17%	25%	25%	24%	27%	24%
Net Profit	42	27	24	36	47	32	43	51
EPS in Rs	2.06	1.34	1.15	1.72	2.25	1.55	2.09	2.44
Raw PDF	—	—	—	—	—	—	—	—

METROPOLIS profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	665	816	1,157	1,066	1,103	1,216	1,365	1,415
Expenses	489	574	833	792	840	944	1,023	1,059
Operating Profit	176	242	324	274	263	272	342	355
OPM %	26%	30%	28%	26%	24%	22%	25%	25%
Other Income	5	49	32	21	12	18	8	11
Interest	10	9	25	31	27	23	23	20
Depreciation	31	36	60	85	91	105	116	116
Profit before tax	140	246	272	179	157	162	212	230
Tax %	20%	20%	27%	22%	26%	23%	26%	—
Net Profit	112	198	200	139	116	125	157	172
EPS in Rs	5.53	9.66	9.75	6.78	5.66	6.02	7.60	8.33
Dividend Payout %	36%	21%	21%	29%	18%	0%	66%	—

METROPOLIS balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	10	10	10	10	10	10	10	41
Reserves	405	502	699	829	926	1,021	1,234	1,348
Borrowings	17	54	85	377	268	195	178	182
Other Liabilities	95	122	140	242	230	247	262	299
Total Liabilities	528	688	933	1,459	1,434	1,473	1,685	1,870
Fixed Assets	163	216	251	1,005	1,066	1,120	1,129	1,135
CWIP	6	3	0	6	20	0	0	0
Investments	135	130	131	50	50	90	321	484
Other Assets	224	340	552	398	299	263	235	252
Total Assets	528	688	933	1,459	1,434	1,473	1,685	1,870

METROPOLIS cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	56	156	202	244	238	269	273	318
Cash from Investing Activity	-4	-51	74	-736	47	-82	-194	-209
Cash from Financing Activity	-64	-46	-26	172	-288	-183	-84	-111
Net Cash Flow	-12	59	250	-320	-3	4	-6	-3
Free Cash Flow	37	133	178	207	189	209	211	281
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	73%	116%	103%	99%	103%	112%	113%	102%

METROPOLIS shareholding pattern (%)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	49.43%	49.40%	48.89%	48.89%	48.89%	48.87%	48.86%	48.86%
FIIs	18.56%	16.73%	15.29%	12.83%	12.52%	11.68%	10.43%	11.03%
DIIs	28.02%	30.00%	30.30%	32.40%	33.10%	34.73%	35.80%	35.12%
Public	3.98%	3.86%	5.51%	5.87%	5.48%	4.69%	4.92%	5.00%
No. of Shareholders	51,852	48,572	49,293	50,015	47,846	46,670	49,175	50,636

METROPOLIS key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	74	68	55	44	43	43	34	32
Inventory Days	52	38	57	66	64	56	47	47
Days Payable	95	155	155	131	133	155	160	166
Cash Conversion Cycle	31	-48	-42	-22	-26	-55	-79	-88
Working Capital Days	47	20	10	-20	-15	-15	-24	-20
ROCE %	38%	35%	37%	28%	17%	15%	13%	16%

METROPOLISUpdated 17 Oct 2026, 19:03

Metropolis Healthcare Ltd

METROPOLISUpdated 17 Oct 2026, 19:03

Market Cap

₹11,003Cr.

Current Price

₹530

High / Low

₹609/412

Stock P/E

61.6

ROE12.2%

ROCE15.9%

Book Value₹67.0

Face Value₹2.00

Dividend Yield0.38%

About

Metropolis Healthcare Limited is one of the leading Indian diagnostics companies. The Company owns a chain of diagnostic centres across India, South Asia, Africa and the Middle East.

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	256	6	198	3	20	35	26	26	1.28
Sep 2023	285	6	218	2	21	42	26	31	1.53
Dec 2023	269	5	211	5	24	35	23	27	1.3
Mar 2024	292	6	218	2	25	45	29	32	1.55
Jun 2024	286	5	218	3	25	42	25	31	1.53
Sep 2024	322	5	240	4	26	55	23	42	2.06
Dec 2024	297	4	232	3	27	37	26	27	1.34
Mar 2025	312	4	259	8	27	29	17	24	1.15
Jun 2025	324	4	247	3	28	48	25	36	1.72
Sep 2025	356	4	264	3	28	62	25	47	2.25
Dec 2025	335	4	255	-6	28	42	24	32	1.55
Mar 2026	352	7	262	9	33	60	27	43	2.09
Jun 2026	372	5	279	5	28	66	24	51	2.44

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	254	2	183	6	10	65	33	43	2.09
Mar 2016	349	1	263	39	12	112	32	76	3.83
Mar 2017	405	2	289	30	12	131	33	88	4.43
Mar 2018	485	3	348	15	14	135	29	96	4.82
Mar 2019	581	3	434	20	15	149	32	101	5.06
Mar 2020	665	10	489	5	31	140	20	112	5.53
Mar 2021	816	9	574	49	36	246	20	198	9.66
Mar 2022	1157	25	833	32	60	272	27	200	9.75
Mar 2023	1066	31	792	21	85	179	22	139	6.78
Mar 2024	1103	27	840	12	91	157	26	116	5.66
Mar 2025	1216	23	944	18	105	162	23	125	6.02
Mar 2026	1365	23	1023	8	116	212	26	157	7.6
TTM	1415	20	1059	11	116	230	—	172	8.33

Shareholding pattern

As of Jun 2026%

Holder	Share
Promoters	48.86%
FIIs	11.03%
DIIs	35.12%
Public	5%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Sep 2023	49.75%	24.29%	16.86%	9.1%
Dec 2023	49.74%	21.66%	20.73%	7.87%
Mar 2024	49.67%	18.9%	24.86%	6.57%
Jun 2024	49.62%	18.25%	27.42%	4.69%
Sep 2024	49.43%	18.56%	28.02%	3.98%
Dec 2024	49.4%	16.73%	30%	3.86%
Mar 2025	48.89%	15.29%	30.3%	5.51%
Jun 2025	48.89%	12.83%	32.4%	5.87%
Sep 2025	48.89%	12.52%	33.1%	5.48%
Dec 2025	48.87%	11.68%	34.73%	4.69%
Mar 2026	48.86%	10.43%	35.8%	4.92%
Jun 2026	48.86%	11.03%	35.12%	5%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	10	296	10	35	351	84	0	175	92	351
Mar 2016	10	233	4	95	341	92	0	120	129	341
Mar 2017	10	258	0	170	438	152	0	143	143	438
Mar 2018	10	354	0	76	440	157	0	98	185	440
Mar 2019	10	405	17	95	528	163	6	135	224	528
Mar 2020	10	502	54	122	688	216	3	130	340	688
Mar 2021	10	699	85	140	933	251	0	131	552	933
Mar 2022	10	829	377	242	1459	1005	6	50	398	1459
Mar 2023	10	926	268	230	1434	1066	20	50	299	1434
Mar 2024	10	1021	195	247	1473	1120	0	90	263	1473
Mar 2025	10	1234	178	262	1685	1129	0	321	235	1685
Mar 2026	41	1348	182	299	1870	1135	0	484	252	1870

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	43	-36	-10	-3
Mar 2016	75	101	-165	11
Mar 2017	77	-67	-17	-6
Mar 2018	74	19	-82	12
Mar 2019	56	-4	-64	-12
Mar 2020	156	-51	-46	59
Mar 2021	202	74	-26	250
Mar 2022	244	-736	172	-320
Mar 2023	238	47	-288	-3
Mar 2024	269	-82	-183	4
Mar 2025	273	-194	-84	-6
Mar 2026	318	-209	-111	-3

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	60	50	56	62	74	68	55	44	43	43	34	32
Inventory Days	50	42	35	49	52	38	57	66	64	56	47	47
Days Payable	71	84	93	87	95	155	155	131	133	155	160	166
Cash Conversion Cycle	38	7	-1	24	31	-48	-42	-22	-26	-55	-79	-88
Working Capital Days	48	12	-47	43	47	20	10	-20	-15	-15	-24	-20
ROCE %	22%	37%	50%	43%	38%	35%	37%	28%	17%	15%	13%	16%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of METROPOLIS HEALTHCARE LTD (METROPOLIS)?

The reported market capitalisation for METROPOLIS HEALTHCARE LTD (METROPOLIS) is ₹11,003Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of METROPOLIS?

The current price shown for METROPOLIS HEALTHCARE LTD (METROPOLIS) on Fincrux is ₹530 with a 52-week high/low of ₹609/412.

What is the P/E ratio of METROPOLIS HEALTHCARE LTD (METROPOLIS)?

The stock P/E for METROPOLIS HEALTHCARE LTD (METROPOLIS) is 61.6 on Fincrux, with ROE at 12.2% and ROCE at 15.9%.

What were METROPOLIS latest quarterly results?

For Jun 2026, METROPOLIS HEALTHCARE LTD (METROPOLIS) reported sales ₹372 Cr and net profit ₹51 Cr (figures in ₹ crore unless noted).

What are METROPOLIS annual sales and net profit?

For TTM, METROPOLIS HEALTHCARE LTD (METROPOLIS) shows sales of ₹1,415 Cr and net profit of ₹172 Cr on the Fincrux profit & loss statement.

Who owns METROPOLIS HEALTHCARE LTD (METROPOLIS)?

Latest shareholding for METROPOLIS HEALTHCARE LTD (METROPOLIS) on Fincrux: Promoters 48.86% (Jun 2026), FIIs 11.03% (Jun 2026), DIIs 35.12% (Jun 2026), Public 5.00% (Jun 2026), No. of Shareholders 50,636% (Jun 2026).

Where can I find METROPOLIS HEALTHCARE LTD (METROPOLIS) financials?

METROPOLIS HEALTHCARE LTD (METROPOLIS) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show METROPOLIS balance sheet and cash flow?

Yes. The METROPOLIS HEALTHCARE LTD (METROPOLIS) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 17 October 2026 at 19:03